Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02994043 · ClinicalTrials.gov registry record · NA
Alcohol, Inflammation, and Mindfulness Study (AIM)
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT02994043 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 182 participants.
The verdict
NCT02994043, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
The goal of the AIM Study is to examine the effectiveness of Mindfulness Based Relapse Prevention (MBRP) versus Relapse Prevention (RP) for the treatment of Alcohol Use Disorders (AUD) by implementing an 8-week long intervention and examining neurobiological, immunological, and epigenetic characteristics of AUD.
Interventions
- BEHAVIORAL Relapse Prevention Therapy
- BEHAVIORAL Mindfulness-Based Relapse Prevention Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2016-11-09 |
| Est. Completion | 2021-02-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02994043
The ClinicalTrials.gov registry entry for NCT02994043 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Relapse Prevention Therapy is the first listed.
NCT02994043 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02994043 about?
NCT02994043 is a clinical study titled "Alcohol, Inflammation, and Mindfulness Study (AIM)". The goal of the AIM Study is to examine the effectiveness of Mindfulness Based Relapse Prevention (MBRP) versus Relapse Prevention (RP) for the treatment of Alcohol Use Disorders (AUD) by implementing an 8-week long intervention and examining neurobiological, immunological, and epigenetic characteri...
What is the current status of trial NCT02994043?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2016-11-09. Estimated completion is 2021-02-17.
What interventions are being tested in trial NCT02994043?
The interventions under investigation include: Relapse Prevention Therapy (BEHAVIORAL), Mindfulness-Based Relapse Prevention Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02994043?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.